Nymisha Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 29-12-2024
- Paid Up Capital ₹ 0.10 M
as on 29-12-2024
- Company Age 4 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 439.27%
(FY 2023)
- Profit 284.90%
(FY 2023)
- Ebitda 410.34%
(FY 2023)
- Net Worth 300.08%
(FY 2023)
- Total Assets 155.65%
(FY 2023)
About Nymisha Life Sciences
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Bala Chavva and Venkatasatya Pericherla serve as directors at the Company.
- CIN/LLPIN
U24290AP2020PTC115438
- Company No.
115438
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Visakhapatnam, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Nymisha Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Venkatasatya Pericherla  | Director | 22-Aug-2020 | Current |
| Bala Chavva | Director | 22-Aug-2020 | Current |
Financial Performance of Nymisha Life Sciences.
Nymisha Life Sciences Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 439.27% increase. The company also saw a substantial improvement in profitability, with a 284.9% increase in profit. The company's net worth Soared by an impressive increase of 300.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nymisha Life Sciences?
Unlock access to Nymisha Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Lotus Botanicals LlpActive 7 years 5 monthsBala Chavva and Venkatasatya Pericherla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Nymisha Life Sciences?
Nymisha Life Sciences has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nymisha Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nymisha Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.